Frontiers in Medicine launches a call for papers on cancer organoid co-culture models, with Prof. Uwe Ritter, Dr. Talita Glaser and Dr. Rupert Ecker (CEO, TissueGnostics) as topic editors. Deadline: 03.09.2025.

Dr. Lukas Kenner presents his research on STAT3’s dual role in prostate cancer. TissueFAXS, HistoQuest, and StrataQuest enabled whole-slide imaging and single-cell quantification.

As part of MTPConnect’s Researcher Exchange and Development Within Industry (REDI) initiative, Australian Prof. Jyotsna Batra, an expert in molecular genetics of prostate cancer, formally joined forces with TissueGnostics for a two years project to develop a clinical in-situ test for prostate cancer diagnostics.

Precision medicine is reshaping healthcare by tailoring treatment to each patient’s molecular profile. With tools like tissue cytometry, TissueFAXS, and StrataQuest, researchers can uncover genetic drivers, track therapy response, and advance personalized care.

Dr. Rupert Ecker co-authored a review on genomic and phenotypic biomarkers guiding precision medicine in advanced prostate cancer, highlighting strategies for diagnosis, prognosis, and treatment prediction.

Deep learning has become a powerful tool in biomedical imaging, enabling accurate cell segmentation, phenotype detection, and analysis of complex tissue structures. TissueGnostics offers AI-driven nuclei segmentation to improve efficiency and precision in image analysis.

FISH enables precise detection of genetic aberrations in cells and is widely applied in diagnostics and personalized medicine. TissueGnostics’ StrataQuest IF Dots App streamlines FISH analysis by automating dot detection and quantification for high-quality data.

How does FISH image analysis advance digital pathology? Learn how whole-slide imaging and AI-powered algorithms enable fast, accurate detection of chromosomal abnormalities, streamline workflows, and open new possibilities for precision medicine.

Yan et al. identified COL8A1 as a potential biomarker of poor chemotherapy response and survival in PDAC. TissueFAXS and StrataQuest enabled imaging and segmentation of tumor structures.